Nabumetone
Product Images NDC 33261-078

Product Visual Gallery

This gallery contains 12 technical images submitted to the FDA as part of the official labeling for Nabumetone (NDC 33261-078). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Aidarex Pharmaceuticals Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structural Formula Of Nabumetone (Nabumetone 750mg Tab For Invagen 1)

Chemical structure of nabumetone shown as a 2-naphthylmethoxy ketone with molecular formula C15H16O2 and molecular weight 228.3.*

FDA Label Image

Nsaid Medications That Need A Prescription (Nabumetone 750mg Tab For Invagen 10)

A table listing generic names of drugs alongside their tradenames. The table includes entries such as Celecoxib with tradename Celebrex, Diclofenac with Cataflam and Voltaren, Ibuprofen with Motrin and others, and Nabumetone with tradename Relafen.*

FDA Label Image

Glenmark Logo (Nabumetone 750mg Tab For Invagen 11)

FDA Label Image

Image Label (Nabumetone 750mg Tab For Invagen 12)

Nabumetone 750 mg film-coated tablets packaging label from Aidarex Pharmaceuticals LLC. The label states the package contains 126 tablets. It includes the generic name Nabumetone and NDC 33261-0078-97, with manufacturer Invagen Pharmaceuticals Inc. located in Hauppauge, NY. The label also shows dosing instruction fields and cautionary storage information.*

FDA Label Image

6mna (Nabumetone 750mg Tab For Invagen 2)

Chemical structure of 6-methoxy-2-naphthylacetic acid (6MNA), the active metabolite of nabumetone, depicting its aromatic rings, methoxy group, and carboxylic acid moiety.*

FDA Label Image

Table 1 (Nabumetone 750mg Tab For Invagen 3)

A pharmacokinetic data table comparing young adults and elderly subjects taking Nabumetone, showing mean and standard deviation values for Tmax (hr), t1/2 (hr), clearance (CLss/F mL/min), and volume of distribution (Vdss/F L) at 1,000 mg and 2,000 mg doses.*

FDA Label Image

6mna Plasma Concentrations (Nabumetone 750mg Tab For Invagen 4)

A line graph showing plasma concentrations of Nabumetone active metabolite (6MNA) at steady state over 70 hours after once-daily dosing of Nabumetone at 1000 mg and 2000 mg. The chart includes concentration ranges with +2 and -2 standard deviations for both dosages, indicating their concentration fluctuations over time.*

FDA Label Image

Metabolites (Nabumetone 750mg Tab For Invagen 5)

A data table listing metabolites of nabumetone and their relative percentages of dose. It includes unchanged nabumetone (not detectable), 6-methoxy-2-naphthylacetic acid (unchanged <1%, conjugated 11%), 6-hydroxy-2-naphthylacetic acid (unchanged 5%, conjugated 7%), 4-(6-hydroxy-2-naphthyl)-butan-2-ol (conjugated 9%), O-desmethyl-nabumetone (conjugated 7%), unidentified minor metabolites (34%), and a total dose percentage of 73%.*

FDA Label Image

Table 2 (Nabumetone 750mg Tab For Invagen 6)

A data table showing the number of patients treated with different doses of Nabumetone in osteoarthritis (OA) and rheumatoid arthritis (RA), along with the mean and mode duration of treatment in years for each dose group.*

FDA Label Image

Side Effects Table (Nabumetone 750mg Tab For Invagen 7)

A drug facts panel listing serious side effects and other side effects of Nabumetone. Serious side effects include heart attack, stroke, high blood pressure, heart failure, kidney problems, bleeding and ulcers in the stomach and intestine, anemia, life-threatening skin and allergic reactions, liver problems, and asthma attacks. Other side effects include stomach pain, constipation, diarrhea, gas, heartburn, nausea, vomiting, and dizziness.*

FDA Label Image

Get Emergency Help If You Experience These Symptoms (Nabumetone 750mg Tab For Invagen 8)

A text panel listing potential serious side effects, including shortness of breath or trouble breathing, chest pain, weakness in one part or side of the body, slurred speech, and swelling of the face or throat.*

FDA Label Image

Stop Nsaid If You Experience These Symptoms (Nabumetone 750mg Tab For Invagen 9)

A text panel listing symptoms and warning signs to watch for, including nausea, fatigue, itching, jaundice, stomach pain, flu-like symptoms, vomiting blood, unusual bowel movements, weight gain, skin rash or blisters with fever, and swelling of extremities.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.